Published on May 10th, 2012 | by James Johnson0
FDA Preparing To Endorse First-Ever HIV Prevention Drug
Doctors have used the Truvada HIV drug to treat HIV infected patients since it was approved for open market use in 2004 and now Food and Drug Administration (FDA) officials are preparing to clear the way for the drug to be the first HIV prevention option available on the open market.
After a series of votes an advisory panel this week recommended that the drug be approved for healthy people who are at a high risk of contracting HIV, specifically gay and bisexualmen and heterosexual couples in which one person is HIV-infected.
While the FDA is not required to follow the advisory panels suggestions it typically does. In any case a final decision is expected to be announced by June 15.
Truvada is already marketed by maker Gilead Sciences Inc., as a treatment for HIV infected people.